Giovanna Russelli
Overview
Explore the profile of Giovanna Russelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez Aleman G, Vavougios G, Tartaglia C, Uvais N, Guekht A, Hosseini A, et al.
Front Aging Neurosci
. 2025 Jan;
16:1432357.
PMID: 39839305
Cognitive changes associated with PASC may not be uniform across populations. We conducted individual-level pooled analyses and meta-analyses of cognitive assessments from eight prospective cohorts, comprising 2,105 patients and 1,432...
2.
Avorio F, Russelli G, Alduino R, Arcadipane A, Gruttadauria S, Lo Re V
Transplant Proc
. 2025 Jan;
57(2):324-331.
PMID: 39824671
Background: After encephalopathy, epileptic seizures (ES) are the second most common neurologic complication after orthotopic liver transplantation (OLT) and may announce a disabling/fatal neurologic disease. Methods: In this retrospective study,...
3.
Avorio F, Russelli G, Panarello G, Alduino R, Conaldi P, Lo Re V
Front Neurol
. 2024 Jul;
15:1393104.
PMID: 39026584
Introduction: SARS-CoV-2 infection can lead to a broad range of neurological manifestations such as olfactory and gustative disorders, myalgias, headache, and fatigue but also more rare and severe neurological pictures...
4.
Kimura M, Rinaldi M, Kothari S, Giannella M, Anjan S, Natori Y, et al.
Am J Transplant
. 2024 May;
24(11):2092-2107.
PMID: 38801991
Invasive aspergillosis (IA) is a rare but fatal disease among liver transplant recipients (LiTRs). We performed a multicenter 1:2 case-control study comparing LiTRs diagnosed with proven/probable IA and controls with...
5.
Lo Re V, Russelli G, Lo Gerfo E, Alduino R, Bulati M, Iannolo G, et al.
Front Neurol
. 2023 Sep;
14:1209905.
PMID: 37693766
Objective: Mechanisms of neurocognitive injury as post-operative sequelae of coronary artery bypass grafting (CABG) are not understood. The systemic inflammatory response to surgical stress causes skeletal muscle impairment, and this...
6.
Giacobbe D, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, et al.
Crit Care
. 2023 Aug;
27(1):323.
PMID: 37620828
Background: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, life-threatening disease commonly affecting immunocompromised patients. The distribution of predisposing diseases or conditions in critically ill patients admitted to intensive care unit...
7.
Giacobbe D, Marelli C, Cattardico G, Fanelli C, Signori A, Di Meco G, et al.
J Antimicrob Chemother
. 2023 Aug;
78(10):2505-2514.
PMID: 37606528
Objectives: To assess the impact of carbapenem resistance on mortality in Klebsiella pneumoniae bloodstream infection (BSI) in the era of novel β-lactam/β-lactamase inhibitor combinations. Material And Methods: Retrospective study of...
8.
Perez-Nadales E, Fernandez-Ruiz M, Natera A, Gutierrez-Gutierrez B, Mularoni A, Russelli G, et al.
Am J Transplant
. 2023 Apr;
23(7):1022-1034.
PMID: 37028515
We aimed to compare the efficacy of ceftazidime-avibactam (CAZ-AVI) versus the best available therapy (BAT) in solid organ transplant (SOT) recipients with bloodstream infection caused by carbapenemase-producing Klebsiella pneumoniae (CPKP-BSI)....
9.
Busa R, Miele M, Sorrentino M, Amico G, Timoneri F, Miceli V, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499373
At present, there is a lack of clinical evidence about the impact and long-term durability of the immune response induced by the third dose of mRNA vaccines. In this study,...
10.
Busa R, Russelli G, Miele M, Sorrentino M, Di Bella M, Timoneri F, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298854
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than the general population, and nowadays, vaccination is the key preventative strategy. Nonetheless, SOTRs show lower vaccine efficacy...